021-51111890
购物车（）
sales@molnova.cn
Azido-PEG9-azide
CAS No. 1171122-72-7
Azido-PEG9-azide ( —— )
产品货号. M26899 CAS No. 1171122-72-7
Azido-PEG9-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ￥794 | 有现货 |
|
| 100MG | ￥1272 | 有现货 |
|
| 200MG | ￥1814 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Azido-PEG9-azide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Azido-PEG9-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
产品描述Azido-PEG9-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体STAT3
-
研究领域——
-
适应症——
化学信息
-
CAS Number1171122-72-7
-
分子量508.6
-
分子式C20H40N6O9
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[N-]=[N+]=NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Madoux F, et al. Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Activators). 2009 Aug 27 [updated 2010 Dec 16]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.
产品手册
关联产品
-
Artemetin
Artemetin protects endothelial function by acting as antioxidant and antiapoptotic agent and through the activation of ERK1/2 and Akt.
-
3-Acetylindole
3-Acetylindole can be used as a substituent and a probe to L-tryptophan for Sudlow site II.
-
Metastin (human)
Potent endogenous ligand of the kisspeptin receptor (KISS1, GPR54). Binds with high affinity to rat and human KISS1 receptors with Ki values of 1.80 and 1.45 nM respectively. Inhibits chemotaxis, invasion and metastasis of human melanomas and breast carcinomas. Stimulates gonadotropin secretion following i.c.v. administration.
